HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xinxiu Yang Selected Research

ginsenoside Rd

3/2021Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xinxiu Yang Research Topics

Disease

1Hepatocellular Carcinoma (Hepatoma)
03/2021

Drug/Important Bio-Agent (IBA)

1ginsenoside RdIBA
03/2021
1fosbretabulin (combretastatin A4)IBA
03/2021